Sepsis roundtable recommends changes in trials

A roundtable on the treatment of sepsis plans to recommend that clinical trials of the disease pay more attention to improvements in organ failure and dysfunction as clinical end points.

The Roundtable Conference on Clinical Trials for the Treatment of Sepsis, held in Brussels, proposed that drugs that significantly affect organ failure - but show only a trend to improvement in survival - should be seen as demonstrating efficacy.